Failure of Initial Therapy With Two Nucleosides and Efavirenz Is Not Associated With Early Emergence of Mutations in the C-Terminus of HIV-1 Reverse Transcriptase-Reference-Cited by-同舟云学术

Failure of Initial Therapy With Two Nucleosides and Efavirenz Is Not Associated With Early Emergence of Mutations in the C-Terminus of HIV-1 Reverse Transcriptase

Published:2011-04 Issue:4 Volume:56 Page:344-348
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Brehm Jessica H,Lalama Christina M,Hughes Michael D,Haubrich Richard,Riddler Sharon A,Sluis-Cremer Nicolas,Mellors John W

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference19 articles.

1. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc. Natl. Acad. Sci.;Wang;USA,1994

2. Update of the Drug Resistance Mutations in HIV-1.;Johnson;Top HIV Med,2008

3. Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase.;Cane;AIDS,2007

4. Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors.;Hachiya;J Virol,2008

5. Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients.;Hachiya;Antiviral Res,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance Mechanisms to HIV-1 Nucleoside Reverse Transcriptase Inhibitors;Antimicrobial Drug Resistance;2017

2. Early selection of resistance-associated mutations in HIV-1 RT C-terminal domains across different subtypes: role of the genetic barrier to resistance;Journal of Antimicrobial Chemotherapy;2014-06-19

3. Efavirenz Stimulates HIV-1 Reverse Transcriptase RNase H Activity by a Mechanism Involving Increased Substrate Binding and Secondary Cleavage Activity;Biochemistry;2013-07-09

4. Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance;Virology;2013-01

5. Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors;Clinical Infectious Diseases;2012-05-22